182 related articles for article (PubMed ID: 34958427)
1. Effectiveness and Tolerability of Trimetazidine 80 Mg Once Daily in Patients with Stable Angina Uncontrolled with Bisoprolol-Based Therapy: The Modus Vivendi Observational Study.
Lopatin Y; Petrova P;
Cardiol Ther; 2022 Mar; 11(1):93-111. PubMed ID: 34958427
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Long-acting Trimetazidine in Different Clinical Situations in Patients with Stable Angina Pectoris: Findings from ODA Trial.
Glezer MG; Vygodin VA;
Cardiol Ther; 2019 Jun; 8(1):69-78. PubMed ID: 30778909
[TBL] [Abstract][Full Text] [Related]
3. Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice.
Glezer MG; Vygodin VA;
Adv Ther; 2018 Sep; 35(9):1368-1377. PubMed ID: 30105656
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA.
Glezer MG; Vygodin VA;
Cardiol Ther; 2020 Dec; 9(2):395-408. PubMed ID: 32430799
[TBL] [Abstract][Full Text] [Related]
5. The Effectiveness of Trimetazidine Treatment in Patients with Stable Angina Pectoris of Various Durations: Results from the CHOICE-2 Study.
Glezer M;
Adv Ther; 2018 Jul; 35(7):1103-1113. PubMed ID: 29766461
[TBL] [Abstract][Full Text] [Related]
6. Trimetazidine and Bisoprolol to Treat Angina in Symptomatic Patients: Post Hoc Analysis From the CHOICE-2 Study.
Glezer M;
Cardiol Ther; 2021 Jun; 10(1):161-173. PubMed ID: 33247333
[TBL] [Abstract][Full Text] [Related]
7. Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study.
Chazov EI; Lepakchin VK; Zharova EA; Fitilev SB; Levin AM; Rumiantzeva EG; Fitileva TB
Am J Ther; 2005; 12(1):35-42. PubMed ID: 15662290
[TBL] [Abstract][Full Text] [Related]
8. Real-world Evidence for the Antianginal Efficacy of Trimetazidine from the Russian Observational CHOICE-2 Study.
Glezer M;
Adv Ther; 2017 Apr; 34(4):915-924. PubMed ID: 28220388
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the antianginal effectiveness of trimetazidine in a new dosage form for a single dose, depending on the region of the Russian Federation. ODA trial results].
Glezer MG; Vygodin VA
Kardiologiia; 2019 Sep; 59(10S):52-63. PubMed ID: 31876462
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and Tolerability of the Single-Pill Combination of Bisoprolol and Perindopril in Patients with Arterial Hypertension and Stable Coronary Artery Disease in Daily Clinical Practice: The STYLE Study.
Boytsov SA; Burtsev YP; Khomitskaya YV; Karpov YA;
Adv Ther; 2021 Jun; 38(6):3299-3313. PubMed ID: 33991323
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study.
Kobalava Z; Kvasnikov B; Burtsev Y;
Adv Ther; 2023 Jun; 40(6):2725-2740. PubMed ID: 37029871
[TBL] [Abstract][Full Text] [Related]
12. [Triple antianginal combinations in the treatment of elderly and senile patients with stable angina].
Kanorskii SG; Smolenskaya NV
Ter Arkh; 2016; 88(12):33-40. PubMed ID: 28139557
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the efficiency of combined pharmacotherapy with the use of trimetazidine with prolonged release in patients with stable angina in outpatient practice].
Luneva YV; Povetkin SV
Ter Arkh; 2019 Aug; 91(8):18-21. PubMed ID: 32598749
[TBL] [Abstract][Full Text] [Related]
15. Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris.
Pozdnyakov YM;
Cardiol Ther; 2018 Jun; 7(1):61-70. PubMed ID: 29779201
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
[TBL] [Abstract][Full Text] [Related]
17. Bisoprolol in the treatment of chronic stable angina pectoris.
Terol I; Plaza L; Rodrigo F
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S208-12. PubMed ID: 11527131
[TBL] [Abstract][Full Text] [Related]
18. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
Marzilli M; Klein WW
Coron Artery Dis; 2003 Apr; 14(2):171-9. PubMed ID: 12655281
[TBL] [Abstract][Full Text] [Related]
20. The possibilities of using beta-blocker bisoprolol in patients with stable angina with concomitant bronchial asthma.
Grigorieva NY; Ilushina TP; Kolosova KS
Kardiologiia; 2022 Jan; 62(1):32-39. PubMed ID: 35168531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
